Rofin-Sinar Technologies (RSTI) Tops Q3 EPS by 3c

Rofin-Sinar Technologies (NASDAQ: RSTI) reported Q3 EPS of $0.40, $0.03 better than the analyst estimate of $0.37. Revenue for the quarter came in at $125.94 million versus the consensus estimate of $130.9 million.

For earnings history and earnings-related data on Rofin-Sinar Technologies (RSTI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c